Lexicon Pharmaceuticals Inc
LXRX
|
|
| |
|
| Trading Volume | 17,835 |
|
|
3.58 - 1.00 |
| Market Cap Full | $ 443.3M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 7.1% | 56.9% | 27.2% | -47.6% |
| Q2 | - | -23.5% | -5.8% | -11% |
| Q3 | - | -20.1% | -52.4% | 29% |
| Q4 | - | -39.3% | 50% | -20.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 22.2 | 33.2 | -3.6 | -30.8 | 3 | 2.1 | 29.5 | -20.1 | - | - | - | -9.5 |
| 2023 | |||||||||||
| 17.3 | 0.5 | 8 | -1.7 | 38.1 | -30.6 | -12.2 | -14.4 | -36.6 | 13.8 | -14.5 | 44.3 |
| 2022 | |||||||||||
| -20.6 | -33.4 | -1 | -11 | -4.8 | 5.1 | 27.7 | 16 | -12.9 | -10.4 | -0.5 | -10.8 |
| 2021 | |||||||||||
| 145.9 | -14.5 | -18.4 | -17.2 | -9.7 | 4.6 | -22.9 | 33.3 | 1.9 | 10 | -16.4 | -9.8 |
| 2020 | |||||||||||
| -27 | -12.5 | -27 | -3.1 | 1.1 | 4.5 | -2.8 | -9.8 | -17.7 | -22.9 | 37.8 | 123.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.2 | -0.2 | -0.6 |
| Q2 | -0.2 | -0.2 | -0.1 | -0.7 |
| Q3 | -0.2 | -0.1 | -0.2 | 0.7 |
| Q4 | 0 | -0.2 | -0.2 | 0 |
| A | -0.6 | -0.62 | -0.6 | -0.5 |